That is one reason why the drug, flibanserin, helped only a small fraction of women in clinical trials
In the Step 1 trial (note: funded by Novo-Nordisk) of 1,961 individuals, the average weight loss at 68 weeks was 14.9% at the maximum dose of 2.4 mg weekly, equating to 15.3 kg (33.6 lbs) lost compared to 2.6 kg (5.7 lbs) in the placebo group
Sodium, potassium, and magnesium levels can fluctuate during early treatment
Its helpful to understand what Reddit users are experiencing because it gives us an idea of what real users think and worry about, though its equally important to remember that not everyone will have the same experience with a medication
IQVIA blog, September 2025: [16] Maintaining momentum: The next frontier of the obesity market